MedTrace Logo

Serum and Uterine Progesterone Levels and ERA Test.

NCT03456375 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2019-04-03

No results posted yet for this study

Summary

Since the implantation is related with endometrial receptivity, the patient specific plasma progesterone concentration influences this pattern.

Following this hypothesis, the study establishes a correlation between the serum progesterone measured on the day of the endometrial biopsy and the endometrial receptivity with the ERA test.

Conditions

  • Endometrial Receptivity

Sponsors & Collaborators

  • Instituto Valenciano de Infertilidad, IVI VALENCIA

    lead OTHER

Principal Investigators

  • Elena Labarta, MD · IVI Vakencia

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-13
Primary Completion
2019-03-15
Completion
2019-03-15

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03456375 on ClinicalTrials.gov